Composition for hardening soft tissue
AssigneeSony Semiconductor Solutions Corporation
InventorsSang Chul LEE, Say June KIM, Kwan Young JEONG, Ok Hee KIM, Seok Jun JO, Min Jin YOO
Life of this patent
Estimating the term…
Loading patent…
AssigneeSony Semiconductor Solutions Corporation
InventorsSang Chul LEE, Say June KIM, Kwan Young JEONG, Ok Hee KIM, Seok Jun JO, Min Jin YOO
Estimating the term…
The present invention relates to various compounds capable of temporarily hardening soft tissue for surgical suturing of the soft tissue. The compounds according to the present invention can temporarily increase the hardness or tension of soft tissue, thereby improving the suturing efficiency during suturing of the soft tissue, thereby preventing aftereffects or the like from occurring due to insufficient anastomosis. In addition, the compounds according to the present invention can temporarily increase the hardness or tension of soft tissue, particularly pancreas, thereby increasing the suturing efficiency during pancreaticoduodenectomy and effectively preventing pancreatic leakage.
A compound which is a compound represented by the following formula 1 or a pharmaceutically acceptable salt or hydrate thereof:
A pharmaceutical composition for hardening soft tissue, comprising, as an active ingredient, a compound selected from the group consisting of a 8-hydroxyquinoline compound, a derivative thereof, and a pharmaceutically acceptable salt and hydrate thereof.
A method for hardening soft tissue, comprising a step of administering to a subject an effective amount of a compound selected from the group consisting of a 8-hydroxyquinoline compound, a derivative thereof, and a pharmaceutically acceptable salt and hydrate thereof.
A pharmaceutical composition for preventing pancreatic leakage, comprising, as an active ingredient, a compound selected from the group consisting of a 8-hydroxyquinoline compound, a derivative thereof, and a pharmaceutically acceptable salt and hydrate thereof.
A pharmaceutical composition for hardening soft tissue, comprising, as an active ingredient, a compound represented by any one of the following formulas 2 to 9 or a pharmaceutically acceptable salt or hydrate thereof:
A method for hardening soft tissue, comprising a step of administering to a subject an effective amount of a compound represented by any one of the following formulas 2 to 9 or a pharmaceutically acceptable salt or hydrate thereof:
A method for preparing a compound derivative, comprising the steps of:
A method for screening a compound for hardening pancreas, the method comprising the steps of:
Dependencies are inferred from the claim text.